Ind-Swift Laboratories Limited announced the outcome of its Board Meeting held on January 31, 2026. The board approved the un-audited standalone and consolidated financial results for the quarter and nine months ended December 31, 2025, along with the Limited Review Reports from the statutory auditors. Additionally, the company announced significant restructuring and changes in key positions within the Board of Directors and Key Managerial Personnel, effective February 1, 2026, subject to shareholder approval. Mr. Navrattan Munjal, Chairman and Managing Director, has been re-designated as Chairman and Whole-Time Director until March 22, 2028. Mr. Himanshu Jain, Joint Managing Director, is appointed as Managing Director (Domestic Operations) until March 22, 2028. Mr. Sahil Munjal, Whole-Time Director, is appointed as Managing Director (Global Operations) until February 12, 2030. The board also approved the remuneration for Mr. Rishav Mehta for his remaining tenure from March 23, 2026, to March 22, 2028. The company also informed that it is in the process of migrating its website from www.indswiftlabs.com to www.indswiftgroup.com, expected to be completed by March 31, 2026. The Board Meeting commenced at 4:00 PM and concluded at 6:00 PM.
